Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Animal health's safety from patent cliff is an investment stimulator

The long product lifecycles in the animal health sector are a key characteristic for attracting R&D investment, according to George Gunn.

Investments Companion Animals Food Animals

Pet tech start-up Scollar chooses KC as headquarters, ponders partnerships and expansion

Founded in 2015, US-based pet technology start-up Scollar markets a cloud-enabled smart collar that is designed to address every aspect of animal care in an "all-in-one" solution for pets. Previously based in Silicon Valley, it will now be moving its headquarters to Kansas City. Animal Pharm analyst Daniel Willis spoke to Scollar co-founder and chief executive Lisa Tamayo to find out more. 

Equipment & Technology Companion Animals Food Animals

CombiGene makes bid for pet gene therapies through synergistic Panion deal

Shareholders of Panion Animal Health have agreed to accept an acquisition offer from the company's former parent CombiGene.

Companion Animals M&A

Bayer signs monoclonal antibody development deal for pets with adivo

Bayer Animal Health is the latest firm to strengthen its abilities in the growing veterinary antibody therapy space by signing a global collaboration agreement with German start-up adivo.

Bayer Animal Health Companion Animals Deals

Next-generation sequencing at the core of MicroGen Vet's diagnostic offering

US firm MicroGen Vet hopes to bring its diagnostics expertise from human healthcare to bring next-generation sequencing (NGS) to animal health.

Diagnostics Companion Animals R&D

Boehringer bags minority stake in swine tech business SoundTalks

Boehringer Ingelheim Animal Health has acquired a minority stake in Belgian technology specialist SoundTalks.

Boehringer Ingelheim Animal Health Equipment & Technology M&A

Latest Articles

USDA to grant exclusive license to Huvepharma for ASF vaccine work
Elanco supports Cultivian Sandbox's third venture fund
Animal health's safety from patent cliff is an investment stimulator
ELIAS cancer immunotherapy answers the 'three big questions' for investors
Parnell turnaround continues with 39% full-year sales hike
Livestock industry partners release national M bovis eradication plan
PBD Biotech appoints new leader, as chief executive retires
USDA proposes updates to poultry improvement plan
Biogénesis Bagó clinches livestock innovation deal with domestic firm
Erik Haaksma becomes head of Boehringer R&D
MesaGreen targets emergency treatment for canine epileptic seizures
Pet tech start-up Scollar chooses KC as headquarters, ponders partnerships and expansion
Zinpro names new global appointments
Animal Pharm Podcast #19: Argenta's Doug Cleverly on an 'infinite amount of anticipation'
Traverse Biosciences 'at crossroads' for canine periodontal disease candidate
DHS highlights progress of ASF task force, vaccine candidates
Animal Pharm daily alert update, service during Easter break
Vetoquinol begins year with 4% growth, completes Brazilian Acquisition
Industry highlights anti-vax, misinformation issues ahead of World Animal Vaccination Day
CombiGene makes bid for pet gene therapies through synergistic Panion deal
US start-up to bring vagus nerve stimulation to companion animals
Horizon 2020 project looks at next-gen tech to improve fish farming
Gour bags capital increase to drive pipeline development, commercialization
Boehringer sales climb 1.5%, currency drags but Chinese strength shines
Young Stock Mortality Consortium exploring livestock health interventions in Ethiopia
Advertisement

 Recent Tweets from Animal Pharm


Advertisement
Advertisement

Commercial

Black swans and battlegrounds: McKinsey expert predicts 'new rules' for animal health's future

A senior partner at management consultancy firm McKinsey believes the animal health sector is "a tale of two cities".

Markets

Latest From

USDA to grant exclusive license to Huvepharma for ASF vaccine work

Huvepharma is the latest company to join the race to develop the first viable vaccine against African swine fever (ASF).

Huvepharma Vaccines

Elanco supports Cultivian Sandbox's third venture fund

Cultivian Sandbox Ventures has closed its third venture capital fund at $135 million, with backing from long-term supporter Elanco.

Elanco Investments

ELIAS cancer immunotherapy answers the 'three big questions' for investors

ELIAS Animal Health believes its diligence in gathering trial data for its personalized canine cancer drug will help it secure funding and create treatment confidence among veterinarians.

Canine Vaccines

Parnell turnaround continues with 39% full-year sales hike

Australian company Parnell Pharmaceuticals has reported 39% growth for 2018, as turnover came to Aus$26.5 million ($19 million).

Parnell Pharmaceuticals Financial Results

Livestock industry partners release national M bovis eradication plan

Three partners working to eliminate Mycoplasma bovis (M bovis) in New Zealand have launched their 2019 national eradication plan.

Food Animals Policy & Regulation

PBD Biotech appoints new leader, as chief executive retires

UK start-up PBD Biotech has made Mark Hammond its new chief executive.

People
See All

Top Interviews & Analysis

Clint Lewis outlines plan to make Abaxis into broader diagnostics player

Zoetis has gone from a couple of exploratory acquisitions to being a key market player in veterinary diagnostics, according to executive vice president Clint Lewis. Animal Pharm editor Joseph Harvey got the lowdown from Mr Lewis on this relatively new but burgeoning area for Zoetis, while analyst Sian Lazell listened to his opening keynote speech at the recent Animal Health Investment Europe conference in London. 

Zoetis Diagnostics

Jobs ad

Products

Bayer stokes further Seresto growth with launch in China

Bayer Animal Health will stimulate even further growth from its Seresto flea and tick collar after introducing the product to the Chinese market.

Bayer Animal Health China Companion Animals

Latest From

USDA to grant exclusive license to Huvepharma for ASF vaccine work

Huvepharma is the latest company to join the race to develop the first viable vaccine against African swine fever (ASF).

Huvepharma Vaccines

Elanco supports Cultivian Sandbox's third venture fund

Cultivian Sandbox Ventures has closed its third venture capital fund at $135 million, with backing from long-term supporter Elanco.

Elanco Investments

ELIAS cancer immunotherapy answers the 'three big questions' for investors

ELIAS Animal Health believes its diligence in gathering trial data for its personalized canine cancer drug will help it secure funding and create treatment confidence among veterinarians.

Canine Vaccines

Parnell turnaround continues with 39% full-year sales hike

Australian company Parnell Pharmaceuticals has reported 39% growth for 2018, as turnover came to Aus$26.5 million ($19 million).

Parnell Pharmaceuticals Financial Results

Livestock industry partners release national M bovis eradication plan

Three partners working to eliminate Mycoplasma bovis (M bovis) in New Zealand have launched their 2019 national eradication plan.

Food Animals Policy & Regulation

PBD Biotech appoints new leader, as chief executive retires

UK start-up PBD Biotech has made Mark Hammond its new chief executive.

People
See All

Sectors

Pet technology experts underline barriers to success in a crowded space

At the recent Animal Health Investment Europe forum in London, Animal Pharm editor Joseph Harvey led a panel discussion on digital personalization in pet care. He spoke to three companies in this area – Fitbark, Antelliq and Felcana. Below is an excerpt of the panel discussion.

Equipment & Technology Companion Animals R&D

Latest From

USDA to grant exclusive license to Huvepharma for ASF vaccine work

Huvepharma is the latest company to join the race to develop the first viable vaccine against African swine fever (ASF).

Huvepharma Vaccines

Elanco supports Cultivian Sandbox's third venture fund

Cultivian Sandbox Ventures has closed its third venture capital fund at $135 million, with backing from long-term supporter Elanco.

Elanco Investments

ELIAS cancer immunotherapy answers the 'three big questions' for investors

ELIAS Animal Health believes its diligence in gathering trial data for its personalized canine cancer drug will help it secure funding and create treatment confidence among veterinarians.

Canine Vaccines

Parnell turnaround continues with 39% full-year sales hike

Australian company Parnell Pharmaceuticals has reported 39% growth for 2018, as turnover came to Aus$26.5 million ($19 million).

Parnell Pharmaceuticals Financial Results

Livestock industry partners release national M bovis eradication plan

Three partners working to eliminate Mycoplasma bovis (M bovis) in New Zealand have launched their 2019 national eradication plan.

Food Animals Policy & Regulation

PBD Biotech appoints new leader, as chief executive retires

UK start-up PBD Biotech has made Mark Hammond its new chief executive.

People

Latest From

USDA to grant exclusive license to Huvepharma for ASF vaccine work

Huvepharma is the latest company to join the race to develop the first viable vaccine against African swine fever (ASF).

Huvepharma Vaccines

Elanco supports Cultivian Sandbox's third venture fund

Cultivian Sandbox Ventures has closed its third venture capital fund at $135 million, with backing from long-term supporter Elanco.

Elanco Investments

ELIAS cancer immunotherapy answers the 'three big questions' for investors

ELIAS Animal Health believes its diligence in gathering trial data for its personalized canine cancer drug will help it secure funding and create treatment confidence among veterinarians.

Canine Vaccines

Parnell turnaround continues with 39% full-year sales hike

Australian company Parnell Pharmaceuticals has reported 39% growth for 2018, as turnover came to Aus$26.5 million ($19 million).

Parnell Pharmaceuticals Financial Results

Livestock industry partners release national M bovis eradication plan

Three partners working to eliminate Mycoplasma bovis (M bovis) in New Zealand have launched their 2019 national eradication plan.

Food Animals Policy & Regulation

PBD Biotech appoints new leader, as chief executive retires

UK start-up PBD Biotech has made Mark Hammond its new chief executive.

People
See All

Policy & Regulation

Experts err on the side of caution over forthcoming European regulations

A joint conference hosted by AnimalhealthEurope and Klifovet in Munich gave a detailed overview of the new European regulation on veterinary medicines and the impact it will have on product development and lifecycle management. Animal Pharm editor Joseph Harvey was in attendance to gauge the reaction to the proposed new rules.

Policy & Regulation Europe
UsernamePublicRestriction

Register

Advertisement